PharmaKure Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Bankr. Admin/Reorg
PharmaKure General Information
Description
Operator of a clinical-stage pharmaceutical company intended to target neurodegenerative diseases including Alzheimer's, Parkinson's, and other rare diseases. The company's propriety technology allows the diagnosis and monitoring of drug treatment for patients using blood-based biomarkers, enabling the healthcare sector to treat their patients and improve their lives.
Contact Information
Website
www.pharmakure.comCorporate Office
- Alderley Park, Congleton Road
- Nether Alderley, Open Access Lab 19S6
- Macclesfield SK10 4TG
- England, United Kingdom
Corporate Office
- Alderley Park, Congleton Road
- Nether Alderley, Open Access Lab 19S6
- Macclesfield SK10 4TG
- England, United Kingdom
PharmaKure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Admin/Reorg | 17-Jan-2025 | Completed | Bankruptcy: Admin/Reorg | |||
| 5. Reverse Merger | Cancelled | Clinical Trials - Phase 1 | ||||
| 4. Later Stage VC | 05-Apr-2021 | Completed | Clinical Trials - Phase 1 | |||
| 3. Secondary Transaction - Private | 01-Jan-2020 | Completed | Startup | |||
| 2. Later Stage VC | 22-Jul-2019 | $413K | $413K | Completed | Startup | |
| 1. University Spin-Out | 05-Jan-2012 | Completed | Startup |
PharmaKure Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
PharmaKure Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PharmaKure Patents
PharmaKure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202202684-D0 | A treatment that disaggregates and inhibits aggregation of oligomeric proteins in protein aggregation diseases | Inactive | 26-Feb-2022 | ||
| AU-2020251321-A1 | The treatment of protein aggregation diseases | Inactive | 05-Apr-2019 | ||
| CA-3132368-A1 | The treatment of protein aggregation diseases | Pending | 05-Apr-2019 | ||
| EP-3946385-A1 | The treatment of protein aggregation diseases | Inactive | 05-Apr-2019 | ||
| US-20220175841-A1 | The treatment of protein aggregation diseases | Pending | 05-Apr-2019 | A61K35/18 |
PharmaKure Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PharmaKure Acquisitions (1)
PharmaKure’s most recent deal was a Merger/Acquisition with CynapseDx. The deal was made on 05-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CynapseDx | 05-Apr-2021 | Merger/Acquisition | Biotechnology |
PharmaKure FAQs
-
When was PharmaKure founded?
PharmaKure was founded in 2012.
-
Where is PharmaKure headquartered?
PharmaKure is headquartered in Macclesfield, United Kingdom.
-
What is the size of PharmaKure?
PharmaKure has 4 total employees.
-
What industry is PharmaKure in?
PharmaKure’s primary industry is Drug Discovery.
-
Is PharmaKure a private or public company?
PharmaKure is a Private company.
-
What is PharmaKure’s current revenue?
The current revenue for PharmaKure is .
-
How much funding has PharmaKure raised over time?
PharmaKure has raised $5.95M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
